Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.

Chronic renal dysfunction late after liver transplantation

Ari Cohen, Mark D. Stegall, Charles B. Rosen et al. · Liver Transplantation · 2002 · 150 citations · Full text

Transplant Rejection, Glomerulonephritis, Urology +15

Risk factors for renal dysfunction in the postoperative course of liver transplant

Miguel Lebrón Gallardo, M.E. Herrera-Gutiérrez, Gemma Seller Pérez et al. · Liver Transplantation · 2004 · 130 citations · Full text

Solid Organ Transplantation, Surgery, Intensive Care Unit +20

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

Jeffrey C. Dunkelberg · Liver Transplantation · 2003 · 120 citations

Immunology, Hepatic Artery, Pathology +22

Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension

Giuseppe Orlando, Leonardo Baiocchi, Andrea Cardillo et al. · Liver Transplantation · 2006 · 73 citations · Full text

Successful Conversion to Rapamycin for Calcineurin Inhibitor-Related Neurotoxicity Following Liver Transplantation

B. Forgács, Hadar Merhav, Jacqueline A. Lappin et al. · Transplantation Proceedings · 2005 · 66 citations

Pharmacology, Hepatotoxicity, Pharmacotherapy +5